TMS-EEG: An emerging tool to study the neurophysiologic biomarkers of psychiatric disorders

Neuropharmacology. 2021 Oct 1:197:108574. doi: 10.1016/j.neuropharm.2021.108574. Epub 2021 Apr 22.

Abstract

The etiology of psychiatric disorders remains largely unknown. The exploration of the neurobiological mechanisms of mental illness helps improve diagnostic efficacy and develop new therapies. This review focuses on the application of concurrent transcranial magnetic stimulation and electroencephalography (TMS-EEG) in various mental diseases, including major depressive disorder, bipolar disorder, schizophrenia, autism spectrum disorder, attention-deficit/hyperactivity disorder, substance use disorder, and insomnia. First, we summarize the commonly used protocols and output measures of TMS-EEG; then, we review the literature exploring the alterations in neural patterns, particularly cortical excitability, plasticity, and connectivity alterations, and studies that predict treatment responses and clinical states in mental disorders using TMS-EEG. Finally, we discuss the potential mechanisms underlying TMS-EEG in establishing biomarkers for psychiatric disorders and future research directions. This article is part of the special Issue on 'Stress, Addiction and Plasticity'.

Keywords: Biomarker; Electroencephalography (EEG); Psychiatric disorder; TMS–EEG; Transcranial magnetic stimulation (TMS); Treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Electroencephalography / methods*
  • Humans
  • Mental Disorders / diagnosis*
  • Transcranial Magnetic Stimulation / methods*

Substances

  • Biomarkers